US Patent Issued to NANJING UNIVERSITY OF CHINESE MEDICINE on Sept. 15 for "Combined formulation capable of ameliorating gastrointestinal adverse effects caused by oxaliplatin and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,199, issued on Sept. 15, was assigned to NANJING UNIVERSITY OF CHINESE MEDICINE (Nanjing, China).

"Combined formulation capable of ameliorating gastrointestinal adverse effects caused by oxaliplatin and preparation method therefor and use thereof" was invented by Jinao Duan (Nanjing, China), Sheng Guo (Nanjing, China), Wanchen Cui (Nanjing, China) and Haifeng Liu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention is a combined formulation capable of ameliorating gastrointestinal adverse effects caused by oxaliplatin, which comprises Lycium barbarum polysaccharides and Akkermansia muciniphila; the Lyciu...